Healthcare Insights

 The global cholesterol management supplements market is on a strong growth trajectory, fueled by the increasing prevalence of cardiovascular diseases, lifestyle disorders, and rising consumer awareness about preventive healthcare. According to the latest market outlook, the cholesterol management supplements market size is estimated to be valued at US$16.5 billion by 2025 and is projected to reach US$25.5 billion by 2032 , expanding at a compound annual growth rate (CAGR) of 6.4% during the forecast period from 2025 to 2032. The market has witnessed steady demand from 2019 to 2024, and the forecast suggests significant opportunities across product types, end-use categories, and distribution channels. Historical Trends and Market Dynamics Between 2019 and 2024, the cholesterol management supplements market registered consistent growth due to the surge in cholesterol-related disorders globally. Sedentary lifestyles, dietary habits rich in saturated fats, and increased cases of ...

 The North America contraceptive drugs market is entering a high-growth phase, fueled by rising awareness, increasing healthcare access, and technological innovations in women’s health solutions. According to market estimates, the sector is projected to expand from US$ 2.67 billion in 2025 to an impressive US$ 4.79 billion by 2032, registering a robust compound annual growth rate (CAGR) of 8.7% during the forecast period from 2025 to 2032. Historical Trends and Current Market Landscape Between 2019 and 2024, the contraceptive drugs industry in North America witnessed steady development, driven largely by increasing adoption of family planning programs and enhanced accessibility through both retail and digital healthcare channels. The period saw a progressive rise in the uptake of oral contraceptives and hormonal therapies, as well as government initiatives designed to improve reproductive health education. Notably, the COVID-19 pandemic temporarily disrupted access to clinics and ...

 The U.S. retail pharmacy market is set to witness steady growth in the coming decade, fueled by evolving consumer healthcare needs, the growing burden of chronic diseases, and increasing accessibility to both physical and online pharmacy services. According to the latest estimates, the market is projected to expand from US$ 609.2 billion in 2025 to US$ 818.0 billion by 2032, registering a compound annual growth rate (CAGR) of 4.3% during the forecast period. This growth reflects both the rising demand for prescription and over-the-counter (OTC) medicines, as well as the role of retail pharmacies as key hubs in the U.S. healthcare ecosystem. Historical Performance Between 2019 and 2024, the U.S. retail pharmacy industry demonstrated resilience amid challenges including supply chain disruptions, regulatory shifts, and the COVID-19 pandemic. During this period, pharmacies evolved beyond dispensing medicines, embracing patient-centric models such as vaccination services, chronic dise...

 The global glutathione market is witnessing strong momentum, driven by rising consumer awareness about health, growing adoption of dietary supplements, and increasing use of glutathione in pharmaceutical and cosmetic applications. According to market projections, the sector is set to expand at a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2030. The market, which stood at US$0.47 billion in 2023, is expected to reach approximately US$0.85 billion by the end of 2030. With applications spanning healthcare, nutraceuticals, functional foods, and personal care, glutathione is increasingly regarded as a critical antioxidant in supporting human health and wellness. Historical Context and Market Trends Between 2018 and 2022, the glutathione market experienced consistent growth, propelled largely by rising demand for immune-boosting and anti-aging supplements. The COVID-19 pandemic further heightened consumer interest in immune health, accelerating th...

 The global antacids market is on a steady growth trajectory, reflecting increasing demand for effective treatments against digestive disorders such as heartburn, gastroesophageal reflux disease (GERD), and peptic ulcers. According to latest industry estimates, the global antacids market size is projected to be valued at US$7.1 billion in 2025 and is expected to grow to US$8.9 billion by 2032 , registering a CAGR of 3.3% during 2025–2032 . This moderate yet sustained growth is attributed to a combination of lifestyle changes, rising incidence of gastrointestinal problems, growing awareness around self-medication, and the easy availability of antacids across multiple distribution channels. Historical Market Performance (2019–2024) Between 2019 and 2024, the antacids market demonstrated consistent growth despite global economic challenges, including the COVID-19 pandemic. The rise in sedentary lifestyles, stress-related eating habits, and consumption of spicy and fast foods led to ...

 The global skin boosters market is undergoing a period of rapid expansion, with projections suggesting it will grow from US$ 1.48 billion in 2025 to US$ 3.33 billion by 2032 , registering a compound annual growth rate (CAGR) of 12.3% during the forecast period. This surge reflects the increasing global demand for non-invasive and preventative skin rejuvenation treatments. Skin boosters, which involve micro-injections of hyaluronic acid and other biocompatible compounds, are designed to hydrate, revitalize, and improve skin elasticity. These treatments, which sit between traditional skincare and surgical procedures, are gaining traction among consumers seeking natural, radiant, and youthful skin without downtime. The aesthetic medicine sector is shifting from cosmetic cover-ups toward long-term skin health, with skin boosters at the center of this transformation. Rising social media influence, growing awareness of preventative skincare, and higher acceptance of non-invasive pro...

 The U.S. viscosupplementation market is on a path of stable expansion, supported by rising cases of osteoarthritis, advancements in treatment options, and growing patient awareness of minimally invasive therapies. According to industry projections, the market is expected to be valued at US$1,127.6 million in 2025 and reach US$1,611.7 million by 2032 , growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2032. Market Overview Viscosupplementation involves the injection of hyaluronic acid (HA) into joints, primarily the knee, to improve lubrication and reduce pain caused by osteoarthritis. The therapy is increasingly preferred as an alternative to oral medications and surgical interventions, owing to its minimally invasive nature and effectiveness in alleviating discomfort. With osteoarthritis becoming more prevalent among the U.S. population, particularly within the aging demographic, demand for viscosupplementation treatments continues...

 The global online dermatology consultation market is undergoing a significant transformation, fueled by technological advancements, increasing prevalence of skin-related disorders, and the rising demand for accessible healthcare solutions. According to market estimates, the sector is projected to reach US$ 3.1 billion in 2025 , growing at a robust pace to achieve US$ 7.2 billion by 2032 , expanding at a CAGR of 12.7% during the forecast period. This remarkable trajectory highlights the growing reliance on telehealth platforms and digital healthcare ecosystems, which are reshaping how patients seek dermatological care worldwide. Historical Performance (2019–2024) Between 2019 and 2024, the online dermatology consultation market witnessed steady growth, driven primarily by the COVID-19 pandemic, which accelerated telemedicine adoption. Lockdowns and restrictions on physical visits forced patients and healthcare providers to shift toward digital consultations. Dermatology, being a ...

 The global elastography imaging market is set for substantial growth over the next decade, fueled by technological innovation, increased prevalence of chronic diseases, and heightened adoption of non-invasive diagnostic solutions. According to the latest market estimates, the global elastography imaging market size is projected to rise from US$4.6 billion in 2025 to US$7.5 billion by 2032 , reflecting a robust CAGR of 7.2% during the forecast period (2025–2032) . This growth trajectory highlights the rising importance of elastography as a diagnostic imaging tool across multiple medical domains including hepatology, oncology, cardiology, and musculoskeletal disorders. Historical Market Performance (2019–2024) From 2019 to 2024, the elastography imaging market witnessed steady expansion due to increasing healthcare investments, rising burden of liver-related diseases, and improvements in imaging modalities. The adoption curve was driven by technological advancements in ultrasound a...